These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2563231)

  • 21. Oculomotor abnormalities and their clinical correlates in schizophrenia.
    Thaker G; Kirkpatrick B; Buchanan RW; Ellsberry R; Lahti A; Tamminga C
    Psychopharmacol Bull; 1989; 25(3):491-7. PubMed ID: 2626522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Tan YL; Zhou DF; Zhang XY
    Schizophr Res; 2005 May; 74(2-3):263-70. PubMed ID: 15722005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CYP2D6 polymorphism and tardive dyskinesia in schizophrenic patients.
    Lohmann PL; Bagli M; Krauss H; Müller DJ; Schulze TG; Fangerau H; Ludwig M; Barkow K; Held T; Heun R; Maier W; Rietschel M; Rao ML
    Pharmacopsychiatry; 2003; 36(2):73-8. PubMed ID: 12734765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo.
    Paladini CA; Celada P; Tepper JM
    Neuroscience; 1999 Mar; 89(3):799-812. PubMed ID: 10199614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modification of saccadic eye movements by GABA-related substances. I. Effect of muscimol and bicuculline in monkey superior colliculus.
    Hikosaka O; Wurtz RH
    J Neurophysiol; 1985 Jan; 53(1):266-91. PubMed ID: 2983037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voluntary movement dysfunction in Huntington's disease and tardive dyskinesia.
    David AS; Jeste DV; Folstein MF; Folstein SE
    Acta Neurol Scand; 1987 Feb; 75(2):130-9. PubMed ID: 2883804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
    Celada P; Paladini CA; Tepper JM
    Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of chlorpromazine and lorazepam on abnormal antisaccade and no-saccade distractibility.
    Green JF; King DJ
    Biol Psychiatry; 1998 Oct; 44(8):709-15. PubMed ID: 9798074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.
    Chakos MH; Alvir JM; Woerner MG; Koreen A; Geisler S; Mayerhoff D; Sobel S; Kane JM; Borenstein M; Lieberman JA
    Arch Gen Psychiatry; 1996 Apr; 53(4):313-9. PubMed ID: 8634009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in eye tracking during clinical stabilization in schizophrenia.
    Rea MM; Sweeney JA; Solomon CM; Walsh V; Frances A
    Psychiatry Res; 1989 Apr; 28(1):31-9. PubMed ID: 2568005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tardive dyskinesia. Pathophysiological mechanisms and clinical trials.
    Gerlach J
    Encephale; 1988 Sep; 14 Spec No():227-32. PubMed ID: 2905651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dyskinesia: neuropsychological, computerized tomographic, and psychiatric symptom findings.
    Gold JM; Egan MF; Kirch DG; Goldberg TE; Daniel DG; Bigelow LB; Wyatt RJ
    Biol Psychiatry; 1991 Sep; 30(6):587-99. PubMed ID: 1681948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study.
    Elkashef AM; Buchanan RW; Gellad F; Munson RC; Breier A
    Am J Psychiatry; 1994 May; 151(5):752-5. PubMed ID: 7909412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental tardive dyskinesia.
    Gunne LM; Häggström JE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction.
    Margolese HC; Chouinard G; Kolivakis TT; Beauclair L; Miller R
    Can J Psychiatry; 2005 Aug; 50(9):541-7. PubMed ID: 16262110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early course of new-onset tardive dyskinesia in older patients.
    Lacro JP; Gilbert PL; Paulsen JS; Fell R; Bailey A; Juels C; Caligiuri M; McAdams LA; Harris MJ; Jeste DV
    Psychopharmacol Bull; 1994; 30(2):187-91. PubMed ID: 7831454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Internally and externally guided voluntary saccades in unmedicated and medicated schizophrenic patients. Part I. Saccadic velocity.
    Straube A; Riedel M; Eggert T; Müller N
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(1):1-6. PubMed ID: 10195337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basal ganglia abnormalities in tardive dyskinesia. Possible relationship with duration of neuroleptic treatment.
    Dalgalarrondo P; Gattaz WF
    Eur Arch Psychiatry Clin Neurosci; 1994; 244(5):272-7. PubMed ID: 7893773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
    Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
    World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor mechanisms in schizophrenic patients with tardive dyskinesia.
    Vrtunski PB; Alphs LD; Meltzer HY
    Psychiatry Res; 1994 Oct; 54(1):71-86. PubMed ID: 7701030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.